Announcements Trials
Browse Landscape

Status

Recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Gastrointestinal 3Thoracic 2Gynecologic 2CNS 2Tumor-Agnostic 1Other solid neoplasm 1Genitourinary 1Breast 1

Conditions

Neuroblastoma 1Neoplasms 1Craniopharyngioma 1

Interventions

Temozolomide 400Radiotherapy 239Bevacizumab 185Magnetic Resonance Spectroscopy 168Radiosurgery 142Cyclophosphamide 95Irinotecan 79Carboplatin 79Etoposide 78Radiation 76pembrolizumab 70Nivolumab 59Surgical Procedures, Operative 57Filgrastim 56Specimen Handling 53Cisplatin 50Blood Specimen Collection 46Topotecan 45Vincristine 43Melphalan 38Radiotherapy, Intensity-Modulated 36Pemetrexed 36Lomustine 36Ipilimumab 36Everolimus 35Magnetic Resonance Imaging 34Erlotinib Hydrochloride 34Drug Therapy 34Surveys and Questionnaires 33sargramostim 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Tumor Burden × CNS × Clear all
NCT03610906 2026-03-23

Prospective Pilot Study Identifying Clinically Relevant Biological Targets for Medical Therapy

University of Colorado, Denver

Enrolling by invitation
250 enrolled
CNS

Craniopharyngioma, Neoplasms

NCT00588068 2025-10-15

Molecular Characterization of Neuroblastic Tumor: Correlation With Clinical Outcome

Memorial Sloan Kettering Cancer Center

Recruiting
2,070 enrolled
CNS

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡